Stock Market Live June 24, 2026: S&P 500 (SPY) Attempting to Regain Momentum

Investing

AbbVie : ABBV

All AbbVie Articles

600 Articles

David Beren | Jun 12, 2026 at 7:23 AM EDT

Forget JEPI, Goldman’s S&P Income ETF Has Beaten It by 42 Points Since Launch

If you own JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI), you bought it for a reason that still holds. JEPI pays monthly. It…

Alex Sirois | Jun 11, 2026 at 2:22 PM EDT

Up 45% Since 2024: 1 Glaring Reality That Makes AbbVie Stock a Hold at $225

AbbVie (NYSE:ABBV | ABBV Price Prediction) at $224.95 sits at the center of a sharp bull-bear debate. The pharma giant…

Joel South | Jun 10, 2026 at 4:05 PM EDT

3 Dividend Stocks Built for Retirement to Buy in June

Mid-year is when income-focused investors tend to take a hard look at their portfolios. With the second half of 2026…

Drew Wood | Jun 8, 2026 at 1:34 PM EDT

The Dividend Growth Portfolio That Starts at $40,000 a Year and Ends at $150,000

A retiree’s $40,000 dividend income stream sounds modest next to a neighbor’s $90,000. But the growth rate often matters more…

Alex Sirois | Jun 7, 2026 at 10:13 AM EDT

Forget Wall Street’s Ultimate Pharma Value Trap: Here Is a Far Better Stock to Buy Right Now

Bristol Myers Squibb (NYSE:BMY | BMY Price Prediction) is the headline pharma name dividend hunters keep circling, drawn in by…

David Beren | Jun 6, 2026 at 12:11 PM EDT

SCHD’s $85 Billion Strategy Now Concentrates 41 Percent of Your Money in Just Ten Stocks

A 63-year-old retiree with $400,000 parked in the Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) likely picked it for the 100-stock…

Alex Sirois | Jun 3, 2026 at 12:06 PM EDT

AbbVie Delivers 400% Returns Beating The S&P 500 by 139%

Ten years ago, AbbVie (NYSE:ABBV | ABBV Price Prediction) was a one-drug story. Humira, the world’s best-selling medicine, threw off…

Joel South | Jun 3, 2026 at 7:45 AM EDT

This Is What a $1 Million Dividend Portfolio Pays After Taxes

At the 24% federal bracket, a $1 million dividend portfolio generating roughly $45,000 in annual income can hand the IRS…

John Seetoo | May 29, 2026 at 10:01 AM EDT

VYM Climbs 26% In a Year While Its Core Dividend Payers Extend Their Streaks

The Vanguard High Dividend Yield Index Fund ETF Shares (NYSEARCA:VYM) is one of the simplest income vehicles in the market:…

John Seetoo | May 28, 2026 at 11:44 AM EDT

SCHD’s $71.6 Billion Portfolio Delivers 20% Gains Plus 3.3% Yield This Year

Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) has become one of the most-owned dividend funds in the country, with $71.6 billion…

Omor Ibne Ehsan | May 26, 2026 at 9:50 AM EDT

SCHD’s Dividend Quality Filter Now Concentrates 42 Percent of Your Money in Just Ten Stocks

Most investors buy Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) because the fund’s reputation tells them they are buying diversification. SCHD…

Vandita Jadeja | May 25, 2026 at 7:47 AM EDT

Two Paths to Growth: Johnson & Johnson vs AbbVie

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) and AbbVie (NYSE:ABBV) both posted Q1 2026 results that beat revenue expectations…

Joel South | May 23, 2026 at 8:41 AM EDT

The Dividend Stocks That Generate $60,000 Tax-Free Inside a Roth (And What They Cost You in a Taxable Account)

Holding a high-yield dividend portfolio in a taxable account at the 24% federal bracket means writing the IRS a $14,400…

Joel South | May 22, 2026 at 7:36 AM EDT

The Dividend Stocks That Can Replace a $65,000 Income and What They’ll Cost You

Replacing a real paycheck with dividends is the cleanest version of financial independence. The income target here is $65,000 per…

Michael Williams | May 21, 2026 at 7:30 AM EDT

Why retirees are banking on SCHD’s 15-year unbroken dividend streak

The Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) has built its reputation on paying reliable, growing quarterly distributions to income investors,…

1 2 3 4 … 40

AbbVie : ABBV

All AbbVie Articles

Forget JEPI, Goldman’s S&P Income ETF Has Beaten It by 42 Points Since Launch

Up 45% Since 2024: 1 Glaring Reality That Makes AbbVie Stock a Hold at $225

3 Dividend Stocks Built for Retirement to Buy in June

The Dividend Growth Portfolio That Starts at $40,000 a Year and Ends at $150,000

Forget Wall Street’s Ultimate Pharma Value Trap: Here Is a Far Better Stock to Buy Right Now

SCHD’s $85 Billion Strategy Now Concentrates 41 Percent of Your Money in Just Ten Stocks

AbbVie Delivers 400% Returns Beating The S&P 500 by 139%

This Is What a $1 Million Dividend Portfolio Pays After Taxes

VYM Climbs 26% In a Year While Its Core Dividend Payers Extend Their Streaks

SCHD’s $71.6 Billion Portfolio Delivers 20% Gains Plus 3.3% Yield This Year

SCHD’s Dividend Quality Filter Now Concentrates 42 Percent of Your Money in Just Ten Stocks

Two Paths to Growth: Johnson & Johnson vs AbbVie

The Dividend Stocks That Generate $60,000 Tax-Free Inside a Roth (And What They Cost You in a Taxable Account)

The Dividend Stocks That Can Replace a $65,000 Income and What They’ll Cost You

Why retirees are banking on SCHD’s 15-year unbroken dividend streak

Stock Market Live June 24, 2026: S&P 500 (SPY) Attempting to Regain Momentum

Live Nasdaq Composite: Tech Stages a Comeback as Memory Chip Stocks Lead the Rebound

‘He Learned the Wrong Lesson’: Why the SpaceX IPO Windfall Is a Trap for Everyday Investors

The Aftermath: SpaceX Hits Bond Markets for $25 Billion as the Stock Cracks 25% From Its High

Treasury Secretary Scott Bessent Says U.S. Can Achieve 3% GDP Growth Without Reigniting Inflation

'He Learned the Wrong Lesson': Why the SpaceX IPO Windfall Is a Trap for Everyday Investors

Treasury Secretary Scott Bessent Says U.S. Can Achieve 3% GDP Growth Without Reigniting Inflation

Costco Stock Price Prediction: A Path to $1,000 and Double-Digit Upside

Prediction: Home Depot Will Hit $400 on This Date

AbbVie : ABBV

All AbbVie Articles

Forget JEPI, Goldman’s S&P Income ETF Has Beaten It by 42 Points Since Launch

Up 45% Since 2024: 1 Glaring Reality That Makes AbbVie Stock a Hold at $225

3 Dividend Stocks Built for Retirement to Buy in June

The Dividend Growth Portfolio That Starts at $40,000 a Year and Ends at $150,000

Forget Wall Street’s Ultimate Pharma Value Trap: Here Is a Far Better Stock to Buy Right Now

SCHD’s $85 Billion Strategy Now Concentrates 41 Percent of Your Money in Just Ten Stocks

AbbVie Delivers 400% Returns Beating The S&P 500 by 139%

This Is What a $1 Million Dividend Portfolio Pays After Taxes

VYM Climbs 26% In a Year While Its Core Dividend Payers Extend Their Streaks

SCHD’s $71.6 Billion Portfolio Delivers 20% Gains Plus 3.3% Yield This Year

SCHD’s Dividend Quality Filter Now Concentrates 42 Percent of Your Money in Just Ten Stocks

Two Paths to Growth: Johnson & Johnson vs AbbVie

The Dividend Stocks That Generate $60,000 Tax-Free Inside a Roth (And What They Cost You in a Taxable Account)

The Dividend Stocks That Can Replace a $65,000 Income and What They’ll Cost You

Why retirees are banking on SCHD’s 15-year unbroken dividend streak

Stock Market Live June 24, 2026: S&P 500 (SPY) Attempting to Regain Momentum

Live Nasdaq Composite: Tech Stages a Comeback as Memory Chip Stocks Lead the Rebound

‘He Learned the Wrong Lesson’: Why the SpaceX IPO Windfall Is a Trap for Everyday Investors

The Aftermath: SpaceX Hits Bond Markets for $25 Billion as the Stock Cracks 25% From Its High

Treasury Secretary Scott Bessent Says U.S. Can Achieve 3% GDP Growth Without Reigniting Inflation

Featured Reads

'He Learned the Wrong Lesson': Why the SpaceX IPO Windfall Is a Trap for Everyday Investors

Treasury Secretary Scott Bessent Says U.S. Can Achieve 3% GDP Growth Without Reigniting Inflation